Osburn Shelby C, Roberson Paul A, Medler Jessica A, Shake Jacob, Arnold Robert D, Alamdari Nima, Bucci Luke R, Vance Arianne, Sharafi Mastaneh, Young Kaelin C, Roberts Michael D
School of Kinesiology, Auburn University, Auburn, AL, United States.
Harrison School of Pharmacy, Auburn University, Auburn, AL, United States.
Front Nutr. 2021 Jul 13;8:610382. doi: 10.3389/fnut.2021.610382. eCollection 2021.
The purpose of this study was to validate the efficacy of a customized vitamin-mineral supplement on blood biomarkers in pre-menopausal females. Women (21-40 years old) who were apparently healthy were recruited from the local community (ClinicalTrials.gov trial registration NCT03828097). Pretesting (PRE) occurred in the morning 5 ± 2 days following each participant's menses and involved a fasted blood draw, body mass assessment, and blood pressure assessment. Participants were then randomly assigned in a double-blinded fashion to either the multivitamins (MV) ( = 43) or placebo group ( = 51). Participants consumed two capsules per day with breakfast for 12 weeks. Following the trial, participants reported to the laboratory for POST assessments, which replicated PRE procedures. Red blood cell fatty acid and serum micronutrient analyses were performed in a blinded fashion at hematology laboratories. A group × time interaction was observed for serum vitamin D levels ( < 0.001). MV increased levels from PRE to POST (+43.7%, < 0.001), whereas no change occurred in the placebo group. Additionally, 78% of MV participants at PRE exhibited inadequate vitamin D levels (<40 ng/dl), whereas only 30% exhibited levels below this threshold at POST. An interaction was also observed for serum folate levels ( < 0.001). MV increased serum folate from PRE to POST ( < 0.001), whereas no change occurred in the placebo group. Red blood cell omega-3 fatty acid content increased from PRE to POST in the MV group ( < 0.001) and placebo group ( < 0.05), although POST values were greater in the MV group ( < 0.001). An interaction was observed for serum HDL cholesterol levels ( = 0.047), and a non-significant increase in this variable from PRE to POST occurred in the MV group ( = 0.060). Four-day food recalls indicated MV increased intake of omega-3 fatty acids, vitamin D, folate, and other micronutrients. In summary, MV supplementation increased serum vitamin D, serum folate, and red blood cell omega-3 fatty acid levels. However, these data are limited to healthy females, and more research is needed to examine if MV can affect metabolic disturbances in individuals with micronutrient deficiencies.
本研究的目的是验证定制的维生素 - 矿物质补充剂对绝经前女性血液生物标志物的功效。从当地社区招募了明显健康的女性(21 - 40岁)(ClinicalTrials.gov试验注册号NCT03828097)。预测试(PRE)在每位参与者月经结束后5±2天的早晨进行,包括空腹采血、体重评估和血压评估。然后,参与者以双盲方式随机分配到多种维生素(MV)组(n = 43)或安慰剂组(n = 51)。参与者每天早餐时服用两粒胶囊,持续12周。试验结束后,参与者到实验室进行POST评估,重复PRE的程序。红细胞脂肪酸和血清微量营养素分析在血液学实验室以盲法进行。观察到血清维生素D水平存在组×时间交互作用(P < 0.001)。MV组从PRE到POST维生素D水平升高(+43.7%,P < 0.001),而安慰剂组无变化。此外,PRE时MV组78%的参与者维生素D水平不足(<40 ng/dl),而POST时只有30%的参与者低于此阈值。血清叶酸水平也观察到交互作用(P < 0.001)。MV组血清叶酸从PRE到POST升高(P < 0.001),而安慰剂组无变化。MV组和安慰剂组红细胞ω-3脂肪酸含量从PRE到POST均升高(MV组P < 0.001,安慰剂组P < 0.05),尽管MV组POST值更高(P < 0.001)。观察到血清高密度脂蛋白胆固醇水平存在交互作用(P = 0.047),MV组该变量从PRE到POST有不显著的升高(P = 0.060)。为期四天的食物召回表明MV组增加了ω-3脂肪酸、维生素D、叶酸和其他微量营养素的摄入量。总之,补充MV可提高血清维生素D、血清叶酸和红细胞ω-3脂肪酸水平。然而,这些数据仅限于健康女性,需要更多研究来检验MV是否能影响微量营养素缺乏个体的代谢紊乱。